Vikas Goyal, MBA, promoted to Partner to lead growth stage investments in late preclinical and clinical stage biotechnology companies. BOSTON, MASSACHUSETTS / ACCESS Newswire / May 12, 2025 / Longwood ...

The stable outlook reflects S&P Global Ratings’ expectation that Amgen’s revenue and EBITDA will remain stable despite patent ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved teprotumumab (Tepezza), the first medicine licensed ...

Copenhagen, Denmark; Interim Report for the First Quarter Ended March 31, 2025 Highlights EPKINLY® (epcoritamab) approved by the Japan Ministry of Health, Labour and Welfare (MHLW) for additional ...

Copenhagen, Denmark;Interim Report for the First Quarter Ended March 31, 2025Highlights EPKINLY ®(epcoritamab) approved by the Japan Ministry of Health, Labour and Welfare (MHLW) for additional ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) yesterday approved Tepezza (teprotumumab (Tepezza). This ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation for Amgen’s Tepezza ...

Amgen (AMGN) stock in focus as its antibody drug Tepezza becomes U.K.'s first medicine for adults with moderate to severe ...

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options ...

Bender Industries GmbH & Co. KG (Bender) appoints Michael Breuer as CEO and Nicole Bender as CFO. Heinz Nowicki and Dr. Sven Hartung have left the company. - Picture is available at AP - As of 1 May ...

Affinity Technologies, Inc. a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer, today announced that it has closed its previously announced best ...